Mapping human metabolic pathways in the small molecule chemical space

Journal of Chemical Information and Modeling

Volumn 49, Issue 10, 2009, Pages 2272-2289

  Macchiarulo, Antonio ^a   Thornton, Janet M ^a,b   Nobeli, Irene ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULES;

CHEMICAL SPACE; CROSS INTERACTIONS; METABOLIC PATHWAYS; METABOLOMES; QUANTITATIVE APPROACH; SMALL MOLECULES; STATISTICAL MODELING; TOPOLOGICAL DESCRIPTORS;

METABOLISM;

DRUG;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; DRUG EFFECT; FACTUAL DATABASE; HUMAN; LABORATORY DIAGNOSIS; METABOLISM; PHARMACOLOGY; PRINCIPAL COMPONENT ANALYSIS;

ANIMALS; DATABASES, FACTUAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGICAL PROCESSES; PRINCIPAL COMPONENT ANALYSIS;

EID: 70350503056     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci900196u     Document Type: Article

References (47)

1. (1) Hattori, M.; Okuno, Y.; Goto, S.; Kanehisa, M. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. J. Am. Chem. Soc. 2003, 125, 11853-11865. (Pubitemid 37175419)
2. Nobeli, I.; Ponstingl, H.; Krissinel, E. B.; Thornton, J. M. A structurebased anatomy of the E.coli metabolome. J. Mol. Biol. 2003, 334, 697-719.
3. Nobeli, I.; Thornton, J. M. A bioinformatician's view of the metabolome. Bioessays 2006, 28, 534-545.
4. Koch, M. A.; Schuffenhauer, A.; Scheck, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17272-17277.
5. (5) Goto, S.; Okuno, Y.; Hattori, M.; Nishioka, T.; Kanehisa, M. LIGAND: database of chemical compounds and reactions in biological pathways. Nucleic Acids Res. 2002, 30, 402-404. (Pubitemid 34679597)
6. Karp, P. D.; Arnaud, M.; Collado-Vides, J.; Ingraham, J.; Paulsen, I. T.; Saier, M. H. J.; The, E. coli EcoCyc database: No longer just a metabolic pathway database. ASM News 2004, 70, 25-30.
7. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; et al. : HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007, 35 (Database issue), D521-526.
8. Brooksbank, C.; Cameron, G.; Thornton, J. M. The European Bioinformatics Institute's data resources: towards systems biology. Nucleic Acids Res. 2005, 33 (Database issue), D46-53.
9. Oprea, T. I. Chemical space navigation in lead discovery. Curr. Opin. Chem. Biol. 2002, 6, 384-389.
10. Dobson, C. M. Chemical space and biology. Nature 2004, 432, 824-828.
11. (11) Lipinski, C.; Hopkins, A. Navigating chemical space for biology and medicine. Nature 2004, 432, 855-861. (Pubitemid 40037141)
12. Villas-Bôas, S. G. In Metabolome analysis: an introduction; Villas-Bôas, S. G., Roessner, U., Hansen, M. A. E., Smedsgaard, J., Nielsen, J. Eds.; Wiley-Interscience: Hoboken, New Jersey, U.S.A., 2007.
13. Breiman, L. Random forests. Machine Learn. 2001, 45, 5-32.
14. Svetnik, V.; Liaw, A.; Tong, C.; Culberson, J. C.; Sheridan, R. P.; Feuston, B. P. Random forest: a classification and regression tool for compound classification and QSAR modeling. J. Chem. Inf. Comput. Sci. 2003, 43, 1947-1958.
15. Cannon, E. O.; Bender, A.; Palmer, D. S.; Mitchell, J. B. Chemoinformatics-based classification of prohibited substances employed for doping in sport. J. Chem. Inf. Model. 2006, 46, 2369-2380.
16. Ehrman, T. M.; Barlow, D. J.; Hylands, P. J. Virtual screening of Chinese herbs with Random Forest. J. Chem. Inf. Model. 2007, 47, 264-278.
17. (17) Gupta, S.; Aires-de-Sousa, J. Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness. Mol. DiVersity 2007, 11, 23-36. (Pubitemid 46639419)
18. Labute, P. A widely applicable set of descriptors. J. Mol. Graphics Modell. 2000, 18, 464-477.
19. Newman, D. J.; Cragg, G. M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477.
20. Stahura, F. L.; Godden, J. W.; Xue, L.; Bajorath, J. Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations. J. Chem. Inf. Comput. Sci. 2000, 40, 1245-1252.
21. Ertl, P.; Schuffenhauer, A. Cheminformatics analysis of natural products: lessons from nature inspiring the design of new drugs. Prog. Drug. Res. 2008, 66, 219-235.
22. Feher, M.; Schmidt, J. M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 2003, 43, 218-227.
23. Karakoc, E.; Sahinalp, S. C.; Cherkasov, A. Comparative QSAR- and Fragments Distribution Analysis of Drugs, Druglikes, Metabolic Substances, and Antimicrobial Compounds. J. Chem. Inf. Model. 2006, 46, 2167-2182.
24. Lee, M. L.; Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J. Comb. Chem. 2001, 3, 284-289.
25. Henkel, T.; Brunne, R. M.; Muller, H.; Reichel, F. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew. Chem., Int. Ed. Engl. 1999, 38, 643-647.
26. Hata, K.; Koseki, K.; Yamaguchi, K.; Moriya, S.; Suzuki, Y.; Yingsakmongkon, S.; Hirai, G.; Sodeoka, M.; von Itzstein, M.; Miyagi, T. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob. Agents Chemother. 2008, 52, 3484-3491.
27. Marcoff, L.; Thompson, P. D. The role of coenzyme Q10 in statinassociated myopathy: a systematic review. J. Am. Coll. Cardiol. 2007, 49, 2231-2237.
28. (28) Andrade, M. A.; Ouzounis, C.; Sander, C.; Tamames, J.; Valencia, A. Functional classes in the three domains of life. J. Mol. Evol. 1999, 49, 551-557. (Pubitemid 32268711)
29. Cases, I.; de Lorenzo, V.; Ouzounis, C. A. Transcription regulation and environmental adaptation in bacteria. Trends Microbiol. 2003, 11, 248-253.
30. Kanehisa, M.; Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28, 27-30.
31. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
32. (32) Gutteridge, A.; Kanehisa, M.; Goto, S. Regulation of metabolic networks by small molecule metabolites. BMC Bioinf. 2007, 8, 88. (Pubitemid 46510280)
33. Hopkins, A. L.; Groom, C. R. The druggable genome. Nat. Rev. Drug Discovery 2002, 1, 727-730.
34. Horovitz, N. H. On the evolution of biochemical synthesis. Proc. Natl. Acad. Sci. U.S.A. 1945, 31, 153-157.
35. Kim, J.; Copley, S. D. Why metabolic enzymes are essential or nonessential for growth of Escherichia coli K12 on glucose. Biochemistry 2007, 46, 12501-12511.
36. Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 2000, 287, 1964-1969.
37. Jeong, H.; Tombor, B.; Albert, R.; Oltvai, Z. N.; Barabasi, A. L. The large-scale organization of metabolic networks. Nature 2000, 407, 651-654.
38. Hopkins, A. L.; Mason, J. S.; Overington, J. P. Can we rationally design promiscuous drugs. Curr. Opin. Struct. Biol. 2006, 16, 127-136.
39. Paolini, G. V.; Shapland, R. H.; van Hoorn, W. P.; Mason, J. S.; Hopkins, A. L. Global mapping of pharmacological space. Nat. Biotechnol. 2006, 24, 805-815.
40. Yildirim, M. A.; Goh, K. I.; Cusick, M. E.; Barabasi, A. L.; Vidal, M. Drug-target network. Nat. Biotechnol. 2007, 25, 1119-1126.
41. Maggiora, G. M. On outliers and activity cliffs-why QSAR often disappoints. J. Chem. Inf. Model. 2006, 46, 1535.
42. Robertson, J. G. Mechanistic basis of enzyme-targeted drugs. Biochemistry 2005, 44, 5561-5571.
43. Ihlenfeldt, W. D.; Takahashi, H.; Abe, S.; Sasaki, J. Computation and management of chemical properties in CACTVS: An extensible networked approach toward modularity and flexibility. J. Chem. Inf. Comput. Sci. 1994, 34, 109-116.
44. Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008, 36, D901-906.
45. R Development Core Team. R: A language and environment for statistical computing; R Development Core Team: Vienna, Austria, 2005.
46. Steinbeck, C.; Han, Y.; Kuhn, S.; Horlacher, O.; Luttmann, E.; Willighagen, E. The Chemistry Development Kit (CDK): an opensource Java library for Chemo- and Bioinformatics. J. Chem. Inf. Comput. Sci. 2003, 43, 493-500.
47. Kochev, N.; Monev, V.; Bangov, I. Searching Chemical Structures. In Chemoinformatics; Gasteiger, J., Engel, T., Eds.; Wiley-VCH: Weinheim, 2003; pp 291-318.